Tumor apparent diffusion coefficient value and ratio in magnetic resonance imaging on cervical cancer

Authors

  • Trifonia Pingkan Siregar Doctoral Program of Medical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Department of Radiology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Septelia Inawati Wanandi Department of Biochemistry and Molecular Biology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
  • Sawitri Darmiati Department of Radiology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Fitriyadi Kusuma Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Sri Mutya Sekarutami Department of Radiotherapy, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Lisnawati Department of Anatomical Pathology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Joedo Prihartono Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
  • Muhammad Ilyas Department of Radiology, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia
  • Ginva Amalia Department of Radiology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Khalida Ikhlasiya Tajdar Gefariena Elfahmi Department of Radiology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia

DOI:

https://doi.org/10.13181/mji.oa.257715

Keywords:

cervical cancer, diffusion magnetic resonance imaging, magnetic resonance imaging

Abstract

BACKGROUND Diffusion-weighted magnetic resonance imaging (DW-MRI) is a noninvasive, non-contrast sequence for cancer detection. Research involving DW-MRI in cervical cancer has revealed lower apparent diffusion coefficient (ADC) values. This study aimed to evaluate the difference in tumor ADC values and ADC ratios (tumor-to-urine and tumor-to-muscle) with respect to tumor staging (early versus late) and histopathology (squamous cell carcinoma versus adenocarcinoma).

METHODS This retrospective study included 56 patients with cervical cancer, divided into early- and late-stage groups. DW-MRI was performed in all patients, and the tumor ADC value, ADC ratio between the tumor and urine (ADC ratiot−u), and ADC ratio between the tumor and gluteal muscle (ADC ratiot−m) were measured. Statistical methods were employed to assess the difference in the tumor ADC value, ADC ratiot−u, and ADC ratiot−m with respect to cervical cancer stages and histopathological findings.

RESULTS The median tumor ADC value was lower in the early-stage group than in the late-stage cervical cancer (0.75 × 10−3 mm²/s versus 0.8 × 10−3 mm²/s, p = 0.022). However, no differences were observed in ADC ratiot−u and ADC ratiot−m concerning the tumor staging, nor in ADC value, ADC ratiot−u, and ADC ratiot−m concerning histopathological findings (p = 0.29, 0.67 and 0.35, respectively), with no significant differences in the ADC ratiot−u (p = 0.153) and ADC ratiot−m (p = 0.260). In receiver operating characteristic analysis, the tumor ADC value was 75.0% sensitive and 50.0% specific in predicting late-stage cervical cancer with a cut-off value of 0.750 × 10−3 mm2/s.

CONCLUSIONS The median tumor ADC value in early-stage patients was significantly lower than in the late-stage patients, suggesting that tumor ADC value has valuable potential for characterizing cervical cancer staging.

Downloads

References

The Catalan Institute of Oncology (ICO) and the International Agency for Research on Cancer (IARC) Information Centre on HPV and Cancer. Indonesia: Human papillomavirus and related cancer, fact sheet 2023 [Internet]. Barcelona: The Catalan Institute of Oncology (ICO) and the International Agency for Research on Cancer (IARC) Information Centre on HPV and Cancer; 2021 [cited 2021 Apr 20]. Available from: https://hpvcentre.net/statistics/reports/IDN_FS.pdf.

International Agency for Research on Cancer. Cancer today [Internet]. Lyon: International Agency for Research on Cancer; 2021 [cited 2021 Apr 20]. Available from: https://gco.iarc.fr/today/online-analysis-multi-bars.

Nuranna L, Prastasari R, Sutrisna B. Survival of cervical cancer patients and its prognostic factors at Cipto Mangunkusumo Hospital, Jakarta. Med J Indones. 2014;23(3):163-8. https://doi.org/10.13181/mji.v23i3.739

Bourgioti C, Chatoupis K, Moulopoulos LA. Current imaging strategies for the evaluation of uterine cervical cancer. World J Radiol. 2016;8(4):342−54. https://doi.org/10.4329/wjr.v8.i4.342

Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynaecol Obstet. 2018;143 Suppl 2:22−36. https://doi.org/10.1002/ijgo.12611

Vinaik T. Study of response and outcome of treatment of radiotherapy in patients of carcinoma cervix stage IIB-IV with concurrent cisplatin. Int J Med Sci Public Health. 2018;7(8):661-6. https://doi.org/10.5455/ijmsph.2018.0413702052018

Rahakbauw E, Winarto H. Radiotherapy response and related clinicopathological factors of patients with cervical cancer. J Phys Conf Ser. 2018;1073(3):032040. https://doi.org/10.1088/1742-6596/1073/3/032040

Dashottar S, Preeth Pany T, Lohia N. Role of apparent diffusion coefficient as a biomarker in the evaluation of cervical cancer. Indian J Radiol Imaging. 2019;29(1):25−32. https://doi.org/10.4103/ijri.IJRI_441_18

Ministry of Health of the Republic of Indonesia. [Cervical cancer] [Internet]. Jakarta: Ministry of Health of the Republic of Indonesia; 2017 [cited 2021 Apr 12]. Available from: http://kanker.kemkes.go.id/guidelines/backup/PNPKServiks.pdf. Indonesian.

Dappa E, Elger T, Hasenburg A, Düber C, Battista MJ, Hötker AM. The value of advanced MRI techniques in the assessment of cervical cancer: a review. Insights Imaging. 2017;8(5):471−81. https://doi.org/10.1007/s13244-017-0567-0

Liu B, Ma WL, Zhang GW, Sun Z, Zhong JM, Wei MQ, et al. Changes in magnetic resonance T2-weighted imaging signal intensity correlate with concurrent chemoradiotherapy response in cervical cancer. J Contemp Brachytherapy. 2019;11(1):41−7. https://doi.org/10.5114/jcb.2019.83285

Bajgiran AM, Mirak SA, Sung K, Sisk AE, Reiter RE, Raman SS. Apparent diffusion coefficient (ADC) ratio versus conventional ADC for detecting clinically significant prostate cancer with 3-T MRI. AJR Am J Roentgenol. 2019;213(3):W134−42. https://doi.org/10.2214/AJR.19.21365

Tamada T, Prabhu V, Li J, Babb JS, Taneja SS, Rosenkrantz AB. Assessment of prostate cancer aggressiveness using apparent diffusion coefficient values: impact of patient race and age. Abdom Radiol (NY). 2017;42(6):1744−51. https://doi.org/10.1007/s00261-017-1058-y

Barrett T, Priest AN, Lawrence EM, Goldman DA, Warren AY, Gnanapragasam VJ, et al. Ratio of tumor to normal prostate tissue apparent diffusion coefficient as a method for quantifying DWI of the prostate. AJR Am J Roentgenol. 2015;205(6):W585−93. https://doi.org/10.2214/AJR.15.14338

Shaaban MS, Ayad VG, Sharafeldeen M, Salem MA, Atta MA, Ramadan AA. DWI and ADC value versus ADC ratio in the characterization of solid renal masses: radiologic-pathologic correlation. Egypt J Radiol Nucl Med. 2021;52(203). https://doi.org/10.1186/s43055-021-00565-3

Hasan DI, Enaba MM, Abd El-Rahman HM, El-Shazely S. Apparent diffusion coefficient value in evaluating types, stages and histologic grading of cancer cervix. Egypt J Radiol Nucl Med. 2015;46:781-9. https://doi.org/10.1016/j.ejrnm.2015.04.006

Lin Y, Li H, Chen Z, Ni P, Zhong Q, Huang H, et al. Correlation of histogram analysis of apparent diffusion coefficient with uterine cervical pathologic finding. AJR Am J Roentgenol. 2015;204(5):1125−31. https://doi.org/10.2214/AJR.14.13350

Wang M, Huang K, Wong MC, Huang J, Jin Y, Zheng ZJ. Global cervical cancer incidence by histological subtype and implications for screening methods. J Epidemiol Glob Health. 2024;14(1):94−101. https://doi.org/10.1007/s44197-023-00172-7

Rana MK, Singh K, Mahajan MK, Rana AP. Clinicopathological profile of cervical carcinoma: an experience of tertiary care cancer centre. Asian Pac J Cancer Care. 2019;4(3):83-6. https://doi.org/10.31557/apjcc.2019.4.3.83-86

Downloads

Published

2025-05-22

How to Cite

1.
Siregar TP, Wanandi SI, Darmiati S, Kusuma F, Sekarutami SM, Lisnawati, et al. Tumor apparent diffusion coefficient value and ratio in magnetic resonance imaging on cervical cancer. Med J Indones [Internet]. 2025 May 22 [cited 2025 Jun. 21];1(1). Available from: https://mji.ui.ac.id/journal/index.php/mji/article/view/7715

Issue

Section

Clinical Research

Most read articles by the same author(s)

<< < 1 2 3 4 5